Patent number: 5668160
Abstract: A compound of formula (I) wherein Q is oxazol-2-yl, 1,3,4-oxadiazol-2-yl, C.sub.1-4 -oxadiazol-3-yl or 1,2,4-oxadiazol-5-yl; Z is CH or N; A is hydrogen, halogen, C.sub.1-4 alkyl, 1,2,4 alkoxy, cyano, nitro or trifluoromethyl; X is halogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted cycloalkyl, OR.sup.1, SR.sup.1, SOR.sup.1, SO.sub.2 R.sup.1, COR.sup.1, CO.sub.2 R.sup.1, NR.sup.1 R.sup.2 or CONR.sup.1 R.sup.2 ; and R.sup.1 and R.sup.2 are, independently, hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted heteroaryl.
Type:
Grant
Filed:
October 3, 1995
Date of Patent:
September 16, 1997
Assignee:
Zeneca Limited
Inventors:
John Martin Clough, Patrick Jelf Crowley, John Stephen Delaney